1207754-85-5

Usage

Uses

Used in Organic Synthesis:
2-(p-Tolylsulfonyl)-6-oxa-2-azaspiro[2.5]octane is used as a key intermediate in organic synthesis for the creation of various complex organic molecules. Its unique structural features make it a valuable component in the development of new chemical entities.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 2-(p-Tolylsulfonyl)-6-oxa-2-azaspiro[2.5]octane is used as a precursor in the synthesis of potential drug candidates. Its derivatives are under investigation for their pharmacological properties, which may lead to the discovery of new therapeutic agents.
Used in Drug Development:
2-(p-Tolylsulfonyl)-6-oxa-2-azaspiro[2.5]octane is employed as a building block in drug development, where its chemical properties can be harnessed to create novel compounds with potential therapeutic applications. The exploration of its derivatives aims to identify new treatments for various diseases and conditions.
Note: Since the provided materials do not specify particular applications or industries for 2-(p-Tolylsulfonyl)-6-oxa-2-azaspiro[2.5]octane, the uses listed are general and based on the compound's characteristics and potential in the fields of organic synthesis and pharmaceutical research. Further information would be required to detail specific applications or industries.

Upstream product

• 720706-20-7 (4-aminotetrahydro-2H-pyran-4-yl)methanol 
• 98-59-9 p-toluenesulfonyl chloride 

Downstream Products

• 1207755-53-0 benzyl (1S,4aR,6aS,7R,8R,10aR,10bR,12aR,14R,15R)-8-[(1R)-1,2-dimethylpropyl]-14-methoxy-15-[[tetrahydro-4-[[(4-methylphenyl)sulfonyl]amino]-2H-pyran-4-yl]methoxy]-1,6,6a,7,8,9,10,10a,10b,11,12,12a-dodecahydro-1,6a,8,10a-tetramethyl-4H-1,4a-propano-2H-phenanthro[1,2-c]pyran-7-carboxylate 

Relevant academic research and scientific papers

ANTIFUNGAL AGENTS

Novel derivatives of enfumafungin are disclosed herein, along with their pharmaceutically acceptable salts, hydrates and prodrugs. Also disclosed are compositions comprising such compounds, methods of preparing such compounds and methods of using such compounds as antifungal agents and/or inhibitors of (l,3)-β-D-glucan synthase. The disclosed compounds, their pharmaceutically acceptable salts, hydrates and prodrugs, as well as compositions comprising such compounds, salts, hydrates and prodrugs, are useful for treating, and/or preventing fungal infections and associated diseases and conditions.

ANTIFUNGAL AGENTS

Novel derivatives of enfumafungin are disclosed herein, along with their pharmaceutically acceptable salts, hydrates and prodrugs. Also disclosed are compositions comprising such compounds, methods of preparing such compounds and methods of using such compounds as antifungal agents and/or inhibitors of (l,3)-β-D-glucan synthase. The disclosed compounds, their pharmaceutically acceptable salts, hydrates and prodrugs,,as well as compositions comprising such compounds, salts, hydrates and prodrugs, are useful for treating and/or preventing fungal infections and associated diseases and conditions.

ANTIFUNGAL AGENTS

Novel derivatives of enfumafungin are disclosed herein, along with' their pharmaceutically acceptable salts, hydrates and prodrugs. Also disclosed are compositions comprising such compounds, methods of preparing such compounds and method of using such compounds as antifungal agents and/or inhibitors of (l,3)-β-D-glucan synthase. The disclosed compounds, their pharmaceutically acceptable salts, hydrates and prodrugs, as well as compositions comprising such compounds, salts, hydrates and prodrugs, are useful for treating and/or preventing fungal infections and associated diseases and conditions.